MDL-3081 • District of Arizona, Judge David G. Campbell

Bard PowerPort Bellwether Trial Tracker

Updated November 2, 2026. MDL-3081 is being worked out through a five-case bellwether program. The results of these trials, not a settlement, are what will set the value of the litigation. Three cases have now been tried. The second, Divelbliss, returned the first plaintiff verdict on September 4, 2026 ($40 million). The third, Lattanzio, an infection case, ended in a defense verdict for Bard, Law.com reported on October 30, 2026. The fourth, Hicks, a thrombosis case, is set for trial on December 1, 2026. This page is updated after every verdict.

Last Updated: November 2, 2026
6 min read
JPML Data Verified
4 sources cited

Key Takeaways

  • Five bellwethers: Cook, Divelbliss, Lattanzio, Hicks and Sorensen
  • Cook (infection) ended May 2026 in a defense verdict on the decided claims, with a hung jury on design defect
  • Divelbliss (fracture) returned the first plaintiff verdict, $40 million, on September 4, 2026
  • Lattanzio (infection) ended in a defense verdict, Law.com reported on October 30, 2026
  • The two remaining trials are set by case management order: Hicks Dec 1, 2026 and Sorensen Feb 2, 2027
  • Under CMO 48, unresolved cases are transferred or remanded to their home districts after the bellwethers

The Five Bellwethers

Trial Case Injury Catheter material Date Outcome
Trial 1 Cook v. Becton, Dickinson Infection Not publicly specified Apr 21 – early May 2026 Defense verdict on failure to warn, failure to instruct and consumer fraud; hung jury on design defect. No ruling on plaintiff’s post-trial motion for a new trial or judgment as a matter of law had been reported as of early November 2026.
Trial 2 Divelbliss v. Becton, Dickinson Fracture (first to a jury) Silicone Groshong (subclavian) Aug 18 to Sep 4, 2026 Unanimous plaintiff verdict, September 4, 2026: $40 million in compensatory damages, no punitive damages. Jury found strict and negligent design defect and failure to warn; found no manufacturing defect and no fraudulent concealment. Judgment entered Sept 10, 2026. First plaintiff verdict in the MDL and the first fracture case decided by a jury. Bard moved for a new trial on Oct 8, 2026, as reported by HarrisMartin; no ruling has been reported.
Trial 3 Lattanzio v. Becton, Dickinson (No. 24-cv-00680) Infection (bloodstream infection/possible sepsis) Silicone Oct 13 to Oct 30, 2026 (trial window, CMO 42) Defense verdict for Bard, Law.com reported on Oct 30, 2026. Claim-by-claim findings were not available in any public source we could read. Summary judgment had been denied Sept 25, 2026.
Trial 4 Hicks v. Becton, Dickinson (No. 23-cv-01703) Thrombosis ChronoFlex polyurethane (Bard X-Port) Dec 1 to Dec 21, 2026 (First Am. CMO 50) Not yet tried. Summary judgment denied Oct 26, 2026; design defect, failure to warn, concealment and punitive damages claims remain under Missouri law. Judge Jennifer Choe-Groves will preside.
Trial 5 Sorensen v. Becton, Dickinson (No. 23-cv-02557) Not publicly confirmed Not publicly confirmed Feb 2 to Feb 19, 2027 (CMO 42) Not yet tried.

Trials 1 to 3 have been tried; the Lattanzio defense verdict is as reported by Law.com on October 30, 2026, and its claim-by-claim findings have not been made public. The remaining two trial windows are set by case management order: Hicks (December 1 to 21, 2026) under First Amended CMO 50, and Sorensen (February 2 to 19, 2027) under CMO 42. Lattanzio's injury and catheter material are drawn from the court's September 25, 2026 summary-judgment ruling, and Hicks's from its October 26, 2026 summary-judgment ruling; the injury type and catheter material for Sorensen are not confirmed in any source we can verify.

Trial 1: Cook (infection)

The first bellwether, Cook v. Becton, Dickinson, ran from April 21, 2026 into early May 2026. Robert Cook, a Minnesota colorectal-cancer patient, was hospitalized for six days and had chemotherapy delayed about two weeks after his PowerPort became infected. Heading into trial, Judge Campbell had denied nearly all of Bard's summary-judgment motion on March 5, 2026. The jury then returned a defense verdict on the claims it decided, clearing Bard and Becton Dickinson on failure to warn, failure to instruct, and consumer fraud, and hung on the central design-defect claim. Plaintiff moved on June 3, 2026 for a new trial or judgment as a matter of law, arguing faulty jury instructions and time pressure on the jury; the motion was fully briefed on July 15, and no ruling on it had been reported as of early November 2026.

Trial 2: Divelbliss (fracture): $40M plaintiff verdict, September 4, 2026

Divelbliss was the first catheter-fracture case in the MDL to reach a jury, and it produced the first plaintiff verdict in the litigation. The trial began August 18, 2026, and on September 4, 2026 the jury awarded Kimberly Divelbliss $40 million in compensatory damages. It found design defect and failure to warn, found no manufacturing defect and no fraudulent concealment, and declined to award punitive damages (Bard had moved at the July 17 pretrial conference to bifurcate the punitive question). Because Cook was an infection case that hung on design defect, Divelbliss was the first jury to decide the design-defect theory, and it decided it for the plaintiff. The case involved a silicone Groshong catheter placed in the subclavian vein. The court entered judgment on September 10, 2026: $40 million, plus post-judgment interest and costs. Bard moved for a new trial on October 8, 2026, arguing that the award was excessive, as reported by HarrisMartin; no ruling on that motion has been reported. Read our full write-up of the Divelbliss verdict.

Trial 3: Lattanzio (infection): defense verdict, October 2026

Lattanzio v. Becton, Dickinson was tried in the October 13 to 30, 2026 window set by CMO 42, and Law.com reported on October 30, 2026 that the jury returned a defense verdict for Bard. The claim-by-claim findings have not been made public. It was an infection case. The Florida plaintiff's PowerPort, which had a silicone catheter, was implanted on August 16, 2013; the plaintiff developed a staph bloodstream infection and possible sepsis, and the port was removed on December 13, 2013. On September 25, 2026 the court had denied summary judgment, leaving claims for design defect, failure to warn, misrepresentation or concealment, and punitive damages for trial. According to Bloomberg Law, the court also rejected Bard's argument that the claims were time-barred. Two MDL-wide rulings issued September 8 limited defense experts: Dr. Sydnor may not offer design-defect opinions, and Christy Foreman may not offer infection-rate opinions or tell jurors that FDA "approved" the labeling through the 510(k) process. With Lattanzio, both infection cases tried so far have gone to the defense on the decided claims, while the one fracture case produced a plaintiff verdict.

Trials 4 and 5: Hicks and Sorensen

Hicks is set for trial from December 1 to 21, 2026 under First Amended CMO 50 (September 24, 2026), and Judge Choe-Groves will conduct that trial. It is a thrombosis case. According to the court's October 26, 2026 order denying Bard's motion for summary judgment, Judy Hicks of Missouri received a Bard X-Port with a ChronoFlex polyurethane catheter on February 21, 2021 for breast-cancer chemotherapy; the device was occluded with thrombus during some infusions and was surgically removed on August 3, 2022. Missouri law governs. Claims for strict and negligent design defect, strict and negligent failure to warn, concealment, and punitive damages remain for trial, and the court held that Bard had not shown, as a matter of undisputed fact, that the X-Port qualifies for the "unavoidably unsafe product" defense to strict liability. Sorensen is set for February 2 to 19, 2027 under CMO 42. Its injury type and catheter material have not been confirmed in any source we can verify, so we do not state them.

What the program is built to test

The bellwethers are structured to span more than one injury type and more than one catheter material, because the alleged design defect may play differently for infection, fracture, and thrombosis. Fracture claims are only about 12% of the MDL inventory per CMO 48, with infection and thrombosis claims making up the majority, so the order and mix of trials is meant to be representative of the docket rather than of the most dramatic injuries.

What happens after the bellwethers

Judge Campbell set out the fallback in CMO 48: cases not resolved by settlement after the bellwethers are to be transferred or remanded to their home districts for resolution. There is no global settlement and no settlement fund as of November 2026, though Divelbliss produced the first plaintiff verdict ($40 million) on September 4, and we do not publish projected per-case figures because no verified source has published any. In a September 3, 2026 minute entry, the court directed the parties to submit a joint proposal on settlement procedures for the MDL by November 6, 2026, and set a November 13 conference to discuss it. That is a procedural order, not an announced settlement.

Frequently Asked Questions

How many bellwether trials are there in the Bard PowerPort MDL?
Five. The first, Cook, was tried in spring 2026. The second, Divelbliss, was tried in August and September 2026 and produced a $40 million plaintiff verdict. The third, Lattanzio, an infection case tried in October 2026, ended in a defense verdict for Bard, Law.com reported on October 30, 2026. Two remain, each set by case management order: Hicks, a thrombosis case, for December 1 to 21, 2026 (First Amended CMO 50), and Sorensen for February 2 to 19, 2027 (CMO 42).
What happened in the first bellwether trial?
The first bellwether, Cook v. Becton, Dickinson, was an infection case. In early May 2026 the jury cleared Bard and Becton Dickinson on failure to warn, failure to instruct, and consumer fraud, and hung on the central design-defect claim, leaving it unresolved. Plaintiff moved for a new trial or judgment as a matter of law, and no ruling on that motion had been reported as of early November 2026. The first plaintiff verdict came in the second bellwether, Divelbliss, on September 4, 2026.
Why is the Divelbliss trial important?
Divelbliss, tried in August and September 2026, was the first catheter-fracture case in the MDL to reach a jury. On September 4, 2026 the jury returned a $40 million plaintiff verdict, finding design defect and failure to warn and declining punitive damages, and the court entered judgment on September 10, 2026. It is the first plaintiff verdict in the MDL. It involved a silicone Groshong catheter placed in the subclavian vein. Bard moved for a new trial on October 8, 2026, as reported by HarrisMartin; no ruling on that motion has been reported.
What happens to cases that are not bellwethers?
Under CMO 48, cases not resolved by settlement after the bellwether trials are to be transferred or remanded to their home districts for resolution, rather than tried in Arizona. That means a claimant’s own home district may ultimately handle the case.

Sources & References

4 sources cited

• U.S. District Court, District of Arizona: MDL-3081 case management orders (CMO 42, December 5, 2025; CMO 48, May 19, 2026; CMO 49, August 3, 2026; First Amended CMO 50, September 24, 2026)

• Trial reporting on Cook v. Becton, Dickinson (April to May 2026), the Divelbliss verdict (September 4, 2026) and the Lattanzio verdict (Law.com, October 30, 2026); HarrisMartin on Bard's Divelbliss new-trial motion (October 12, 2026)

• Judicial Panel on Multidistrict Litigation: MDL statistics reports

• MDL-3081 docket: Divelbliss judgment (September 10, 2026), minute entry on settlement procedures (September 3, 2026), expert rulings (September 8, 2026), Lattanzio summary-judgment order (September 25, 2026) and Hicks summary-judgment order (October 26, 2026)

Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content.

Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.

Read our full disclaimer · Privacy Policy · Terms of Use